The Role of the New Ca2+ Antagonist, CV159, in Hepatic I/R Injury—The Evaluation of Hepatic Organ Reducing Activity Using In Vivo and Ex Vivo EPR
We investigated the organ-reducing ability of 1,2-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV159) that exhibits selective blocking of Ca2+ /calmodulin and inhibition of Ca2+ overloading in living organisms (Sprague Dawley r...
Saved in:
Published in | The Journal of surgical research Vol. 145; no. 1; pp. 49 - 56 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.03.2008
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We investigated the organ-reducing ability of 1,2-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV159) that exhibits selective blocking of Ca2+ /calmodulin and inhibition of Ca2+ overloading in living organisms (Sprague Dawley rats) using an in vivo and an ex vivo electron paramagnetic imaging technique. Decay rates in CV159-treated rats were significantly higher than those in untreated rats and were almost equal to those in the sham group. Both cytosol and mitochondrial superoxide scavenging activity in CV159-treated rats were significantly higher than those in untreated rats, and cytosol superoxide scavenging activity only was slightly higher than that in the sham group. Faint staining for anti-superoxide dismutase antibody was markedly observed in necrotic lesions in the liver of control group. Alanine aminotransferase level in CV-treated rats were significantly decreased as compared with the levels in untreated rats. Electron microscopy showed a decreased number of damaged mitochondria, whereas mitochondrial damage was significantly reduced in CV-treated animals. We conclude that CV159 retains the organ-reducing activity against radicals in hepatic I/R injury that is mediated by the inhibition of Ca2+ overloading. |
---|---|
AbstractList | We investigated the organ-reducing ability of 1,2-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV159) that exhibits selective blocking of Ca(2+)/calmodulin and inhibition of Ca(2+) overloading in living organisms (Sprague Dawley rats) using an in vivo and an ex vivo electron paramagnetic imaging technique. Decay rates in CV159-treated rats were significantly higher than those in untreated rats and were almost equal to those in the sham group. Both cytosol and mitochondrial superoxide scavenging activity in CV159-treated rats were significantly higher than those in untreated rats, and cytosol superoxide scavenging activity only was slightly higher than that in the sham group. Faint staining for anti-superoxide dismutase antibody was markedly observed in necrotic lesions in the liver of control group. Alanine aminotransferase level in CV-treated rats were significantly decreased as compared with the levels in untreated rats. Electron microscopy showed a decreased number of damaged mitochondria, whereas mitochondrial damage was significantly reduced in CV-treated animals. We conclude that CV159 retains the organ-reducing activity against radicals in hepatic I/R injury that is mediated by the inhibition of Ca(2+) overloading. We investigated the organ-reducing ability of 1,2-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV159) that exhibits selective blocking of Ca 2+/calmodulin and inhibition of Ca 2+ overloading in living organisms (Sprague Dawley rats) using an in vivo and an ex vivo electron paramagnetic imaging technique. Decay rates in CV159-treated rats were significantly higher than those in untreated rats and were almost equal to those in the sham group. Both cytosol and mitochondrial superoxide scavenging activity in CV159-treated rats were significantly higher than those in untreated rats, and cytosol superoxide scavenging activity only was slightly higher than that in the sham group. Faint staining for anti-superoxide dismutase antibody was markedly observed in necrotic lesions in the liver of control group. Alanine aminotransferase level in CV-treated rats were significantly decreased as compared with the levels in untreated rats. Electron microscopy showed a decreased number of damaged mitochondria, whereas mitochondrial damage was significantly reduced in CV-treated animals. We conclude that CV159 retains the organ-reducing activity against radicals in hepatic I/R injury that is mediated by the inhibition of Ca 2+ overloading. We investigated the organ-reducing ability of 1,2-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV159) that exhibits selective blocking of Ca2+ /calmodulin and inhibition of Ca2+ overloading in living organisms (Sprague Dawley rats) using an in vivo and an ex vivo electron paramagnetic imaging technique. Decay rates in CV159-treated rats were significantly higher than those in untreated rats and were almost equal to those in the sham group. Both cytosol and mitochondrial superoxide scavenging activity in CV159-treated rats were significantly higher than those in untreated rats, and cytosol superoxide scavenging activity only was slightly higher than that in the sham group. Faint staining for anti-superoxide dismutase antibody was markedly observed in necrotic lesions in the liver of control group. Alanine aminotransferase level in CV-treated rats were significantly decreased as compared with the levels in untreated rats. Electron microscopy showed a decreased number of damaged mitochondria, whereas mitochondrial damage was significantly reduced in CV-treated animals. We conclude that CV159 retains the organ-reducing activity against radicals in hepatic I/R injury that is mediated by the inhibition of Ca2+ overloading. |
Author | Kamibayashi, Masato, Ph.D Koizumi, Satoshi, Ph.D., M.D Asano, Takayuki, Ph.D., M.D Shimamura, Tsukasa, Ph.D., M.D Asakura, Takeshi, Ph.D., M.D Kobayashi, Hiromichi P., M.D Jinnouchi, Yuji, Ph.D., M.D Ishiuchi, Atsuko, Ph.D Watanabe, Taiji, Ph.D., M.D Nakano, Hiroshi, Ph.D., M.D Kubota, Sunao, Ph.D., M.D Otsubo, Takehito, Ph.D., M.D Oowada, Shigeru, Ph.D., M.D |
Author_xml | – sequence: 1 fullname: Watanabe, Taiji, Ph.D., M.D – sequence: 2 fullname: Oowada, Shigeru, Ph.D., M.D – sequence: 3 fullname: Kobayashi, Hiromichi P., M.D – sequence: 4 fullname: Kamibayashi, Masato, Ph.D – sequence: 5 fullname: Ishiuchi, Atsuko, Ph.D – sequence: 6 fullname: Jinnouchi, Yuji, Ph.D., M.D – sequence: 7 fullname: Koizumi, Satoshi, Ph.D., M.D – sequence: 8 fullname: Asano, Takayuki, Ph.D., M.D – sequence: 9 fullname: Shimamura, Tsukasa, Ph.D., M.D – sequence: 10 fullname: Asakura, Takeshi, Ph.D., M.D – sequence: 11 fullname: Nakano, Hiroshi, Ph.D., M.D – sequence: 12 fullname: Kubota, Sunao, Ph.D., M.D – sequence: 13 fullname: Otsubo, Takehito, Ph.D., M.D |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20122895$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18067923$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks9uEzEQxi1URNPAA3BBvsCFbjq2968qIUVRoJEqikJbcbMc72zwsrHDejeQG-8AT8iT4FUCSBw4ecb-zTfWfHNGTqyzSMhTBhMGLL2oJ7X3Ew6QThifJEnxgIwYFEmUp5k4ISMAzqM4h_iUnHlfQ8iLTDwipyyHNCu4GJHvtx-RLl2D1FW0C_Fb_EJnir-kU9uptbPGd-d0ds-S4pwaS69wqzqj6eJiSRe27tv9z28_Bo35TjV9eHJ2UPqN3bRrZekSy14bu6ZT3Zmd6fb0zg_pwtJ7s3NU2ZLOvx7i-bvlY_KwUo3HJ8dzTO5ez29nV9H1zZvFbHod6QR4F-UJ40LEaVkwyEBkqxXTaZ6pCqDUOReKq6ri4VboMs1KvdIFVpjmsYaYi0yIMXlx0N227nOPvpMb4zU2jbLoei-DKAgRlMaEHUDdOu9brOS2NRvV7iUDOTghaxmckIMTknEZnAg1z47i_WqD5d-K4-gD8PwIKK9VU7XKauP_cBwY53mRBO7ywGEYxc5gK702aDWWpkXdydKZ_37j1T_VujHWhIafcI--dn1rw4wlk55LkO-HlRk2BlJgLI8_iF_ZK7tB |
CODEN | JSGRA2 |
CitedBy_id | crossref_primary_10_1016_j_jss_2007_06_024 crossref_primary_10_1248_bpb_33_77 crossref_primary_10_3389_fcimb_2017_00322 crossref_primary_10_1254_jphs_10033FP crossref_primary_10_1254_jphs_10100FP crossref_primary_10_1016_j_jconrel_2008_12_012 |
Cites_doi | 10.1038/nature03434 10.1161/hh2201.100205 10.1074/jbc.272.1.556 10.1016/j.tox.2005.05.008 10.1159/000090612 10.1016/S0891-5849(99)00280-4 10.1016/S0016-5085(99)70241-6 10.1016/0076-6879(90)86093-B 10.1016/S0891-5849(03)00073-X 10.1016/0730-725X(85)90012-8 10.1097/00005344-200405000-00016 10.1016/S0730-725X(99)00122-8 10.1007/s10620-006-8014-y 10.1074/jbc.271.25.15182 10.1016/S0024-3205(99)00011-9 10.1080/10715760600883254 10.1038/nature03317 10.1161/hh0202.103615 10.1016/0006-2952(88)90685-5 10.1016/0006-291X(82)91089-0 |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2008 Elsevier Inc. 2008 INIST-CNRS |
Copyright_xml | – notice: Elsevier Inc. – notice: 2008 Elsevier Inc. – notice: 2008 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.jss.2006.12.559 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1095-8673 |
EndPage | 56 |
ExternalDocumentID | 10_1016_j_jss_2006_12_559 18067923 20122895 S002248040601184X 1_s2_0_S002248040601184X |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABBQC ABFNM ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEK HMK HMO HVGLF HZ~ IHE J1W J5H KOM LG5 M29 M41 MO0 N9A O-L O9- OAUVE OK- OW- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K UHS WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 08R AAUGY ABPIF ABPTK IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c502t-85123346d9107037bb1c687af00dc823a2aff2bb13cd67dcbc9efe684c0423733 |
IEDL.DBID | .~1 |
ISSN | 0022-4804 |
IngestDate | Fri Oct 25 03:40:32 EDT 2024 Thu Sep 26 18:24:29 EDT 2024 Sat Sep 28 07:51:10 EDT 2024 Sun Oct 22 16:06:01 EDT 2023 Fri Feb 23 02:33:29 EST 2024 Tue Oct 15 22:54:09 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | in vivo EPR CV159 ex vivo EPR CaM hepatic IR injury Evaluation Toxicity Liver Calcium antagonist Cardiovascular disease Inorganic element Medicine In vivo Treatment Ex vivo Surgery Lesion |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c502t-85123346d9107037bb1c687af00dc823a2aff2bb13cd67dcbc9efe684c0423733 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 18067923 |
PQID | 70303382 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_70303382 crossref_primary_10_1016_j_jss_2006_12_559 pubmed_primary_18067923 pascalfrancis_primary_20122895 elsevier_sciencedirect_doi_10_1016_j_jss_2006_12_559 elsevier_clinicalkeyesjournals_1_s2_0_S002248040601184X |
PublicationCentury | 2000 |
PublicationDate | 2008-03-01 |
PublicationDateYYYYMMDD | 2008-03-01 |
PublicationDate_xml | – month: 03 year: 2008 text: 2008-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | The Journal of surgical research |
PublicationTitleAlternate | J Surg Res |
PublicationYear | 2008 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Togashi, Shinzawa, Matsuo (bib5) 2000; 28 Kamibayashi, Oowada, Kameda (bib12) 2006; 40 Baines, Kaiser, Purcell (bib18) 2004; 434 Yamagishi, Inagaki, Nakamura (bib17) 2004; 43 Kuno, Kanada, Nakashima (bib19) 1997; 272 Murata, Akao, O’Rourke (bib20) 2001; 89 Togashi, Matsuo, Shinzawa (bib14) 2000; 18 Li, Mullen, Yun (bib16) 2002; 90 Kazzaz, Xu, Palaia (bib1) 1996; 271 Halliwell, Gutteridge (bib2) 1990; 186 Hirayama, Nagase (bib15) 2006; 103 Thayer, Fairhurst (bib9) 1983; 24 Nakagawa, Shimizu, Watanabe (bib21) 2005; 434 Miyazaki, Tanaka, Fujii (bib10) 1999; 64 Nieuwenhuijs, De Bruijn, Padbury (bib22) 2006; 51 Couet, Brasc, Sosnovsky (bib6) 1985; 3 Epstein, Fiss, Hachisu (bib8) 1982; 105 Hirayama, Yoh, Nagase (bib13) 2003; 34 Umekawa, Yamakawa, Nunoki (bib7) 1988; 37 Swart, Sentjurc, Kocherginsly (bib3) 1995 Kohli, Madden, Bentley (bib11) 1999; 116 Yoshida, Saegusa, Fukuda (bib4) 2005; 213 Miyazaki (10.1016/j.jss.2006.12.559_bib10) 1999; 64 Murata (10.1016/j.jss.2006.12.559_bib20) 2001; 89 Couet (10.1016/j.jss.2006.12.559_bib6) 1985; 3 Epstein (10.1016/j.jss.2006.12.559_bib8) 1982; 105 Yamagishi (10.1016/j.jss.2006.12.559_bib17) 2004; 43 Nakagawa (10.1016/j.jss.2006.12.559_bib21) 2005; 434 Li (10.1016/j.jss.2006.12.559_bib16) 2002; 90 Kohli (10.1016/j.jss.2006.12.559_bib11) 1999; 116 Nieuwenhuijs (10.1016/j.jss.2006.12.559_bib22) 2006; 51 Kazzaz (10.1016/j.jss.2006.12.559_bib1) 1996; 271 Yoshida (10.1016/j.jss.2006.12.559_bib4) 2005; 213 Kuno (10.1016/j.jss.2006.12.559_bib19) 1997; 272 Togashi (10.1016/j.jss.2006.12.559_bib5) 2000; 28 Hirayama (10.1016/j.jss.2006.12.559_bib13) 2003; 34 Swart (10.1016/j.jss.2006.12.559_bib3) 1995 Togashi (10.1016/j.jss.2006.12.559_bib14) 2000; 18 Umekawa (10.1016/j.jss.2006.12.559_bib7) 1988; 37 Kamibayashi (10.1016/j.jss.2006.12.559_bib12) 2006; 40 Baines (10.1016/j.jss.2006.12.559_bib18) 2004; 434 Halliwell (10.1016/j.jss.2006.12.559_bib2) 1990; 186 Thayer (10.1016/j.jss.2006.12.559_bib9) 1983; 24 Hirayama (10.1016/j.jss.2006.12.559_bib15) 2006; 103 |
References_xml | – volume: 37 start-page: 3377 year: 1988 ident: bib7 article-title: Inhibition of calmodulin function by CV159, a novel dihydropyridine compound publication-title: Biochem Pharmacol contributor: fullname: Nunoki – volume: 272 start-page: 556 year: 1997 ident: bib19 article-title: Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene publication-title: J Biol Chem contributor: fullname: Nakashima – volume: 89 start-page: 891 year: 2001 ident: bib20 article-title: Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection publication-title: Circ Res contributor: fullname: O’Rourke – volume: 186 start-page: 1 year: 1990 ident: bib2 article-title: Role of free radicals and catalytic metal ions in human diseases: An overview publication-title: Methods Enzymol contributor: fullname: Gutteridge – volume: 213 start-page: 74 year: 2005 ident: bib4 article-title: Measurement of radical-scavenging ability in hepatic metallothionein of rat using in vivo electron spin resonance spectroscopy publication-title: Toxicology contributor: fullname: Fukuda – volume: 24 start-page: 6 year: 1983 ident: bib9 article-title: The interaction of dihydropyridine calcium channel blocker with calmodulin and calmodulin inhibitors publication-title: Mol Pharmacol contributor: fullname: Fairhurst – volume: 40 start-page: 1166 year: 2006 ident: bib12 article-title: Synthesis and characterization of practically better DEPMPO-type spin trap,5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide (CYPMPO) publication-title: Free Radical Res contributor: fullname: Kameda – start-page: 153 year: 1995 ident: bib3 article-title: Metabolism and distribution of nitroxides in vivo contributor: fullname: Kocherginsly – volume: 64 start-page: 869 year: 1999 ident: bib10 article-title: Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV-159), on rat ischemic brain injury publication-title: Life Sci contributor: fullname: Fujii – volume: 51 start-page: 1087 year: 2006 ident: bib22 article-title: Hepatic ischemia-reperfusion injury: Role of Ca publication-title: Digestive Dis Sci contributor: fullname: Padbury – volume: 105 start-page: 1142 year: 1982 ident: bib8 article-title: Interaction of calcium antagonist with cyclic AMP phosphodiesterases and calmodulin publication-title: Biochem Biophys Res Commun contributor: fullname: Hachisu – volume: 434 start-page: 652 year: 2005 ident: bib21 article-title: Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death publication-title: Nature contributor: fullname: Watanabe – volume: 18 start-page: 151 year: 2000 ident: bib14 article-title: Ex vivo measurement of tissue distribution of nitroxide radical after intravenous injection and its in vivo imaging using a rapid scan ESR-CT system publication-title: Magn Reson Imaging contributor: fullname: Shinzawa – volume: 434 start-page: 658 year: 2004 ident: bib18 article-title: Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death publication-title: Nature contributor: fullname: Purcell – volume: 28 start-page: 846 year: 2000 ident: bib5 article-title: Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging publication-title: Free Radical Bio Med contributor: fullname: Matsuo – volume: 116 start-page: 168 year: 1999 ident: bib11 article-title: Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis publication-title: Gastroenterology contributor: fullname: Bentley – volume: 103 start-page: 71 year: 2006 ident: bib15 article-title: Electron paramagnetic resonance imaging of oxidative stress in renal disease publication-title: Nephron Clin Pract contributor: fullname: Nagase – volume: 43 start-page: 724 year: 2004 ident: bib17 article-title: Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-α-induced interleukin-8 expression in endothelial cells though its antioxidative properties publication-title: J Cardiovasc Pharmacol contributor: fullname: Nakamura – volume: 271 start-page: 15182 year: 1996 ident: bib1 article-title: 1996. Cellular oxygen toxicity publication-title: J Biol Chem contributor: fullname: Palaia – volume: 3 start-page: 83 year: 1985 ident: bib6 article-title: Factors affecting nitroxide reduction in ascorbate solution and tissue homogenate publication-title: Magn Reson Imaging contributor: fullname: Sosnovsky – volume: 34 start-page: 1236 year: 2003 ident: bib13 article-title: EPR imaging of reducing activity in Nrf2 transcriptional factor deficient mice publication-title: Free Radical Bio Med contributor: fullname: Nagase – volume: 90 start-page: 143 year: 2002 ident: bib16 article-title: Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-α publication-title: Cir Res contributor: fullname: Yun – volume: 434 start-page: 658 year: 2004 ident: 10.1016/j.jss.2006.12.559_bib18 article-title: Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death publication-title: Nature doi: 10.1038/nature03434 contributor: fullname: Baines – volume: 89 start-page: 891 year: 2001 ident: 10.1016/j.jss.2006.12.559_bib20 article-title: Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection publication-title: Circ Res doi: 10.1161/hh2201.100205 contributor: fullname: Murata – volume: 272 start-page: 556 year: 1997 ident: 10.1016/j.jss.2006.12.559_bib19 article-title: Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene publication-title: J Biol Chem doi: 10.1074/jbc.272.1.556 contributor: fullname: Kuno – volume: 213 start-page: 74 year: 2005 ident: 10.1016/j.jss.2006.12.559_bib4 article-title: Measurement of radical-scavenging ability in hepatic metallothionein of rat using in vivo electron spin resonance spectroscopy publication-title: Toxicology doi: 10.1016/j.tox.2005.05.008 contributor: fullname: Yoshida – volume: 103 start-page: 71 year: 2006 ident: 10.1016/j.jss.2006.12.559_bib15 article-title: Electron paramagnetic resonance imaging of oxidative stress in renal disease publication-title: Nephron Clin Pract doi: 10.1159/000090612 contributor: fullname: Hirayama – volume: 24 start-page: 6 year: 1983 ident: 10.1016/j.jss.2006.12.559_bib9 article-title: The interaction of dihydropyridine calcium channel blocker with calmodulin and calmodulin inhibitors publication-title: Mol Pharmacol contributor: fullname: Thayer – volume: 28 start-page: 846 year: 2000 ident: 10.1016/j.jss.2006.12.559_bib5 article-title: Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging publication-title: Free Radical Bio Med doi: 10.1016/S0891-5849(99)00280-4 contributor: fullname: Togashi – volume: 116 start-page: 168 year: 1999 ident: 10.1016/j.jss.2006.12.559_bib11 article-title: Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70241-6 contributor: fullname: Kohli – volume: 186 start-page: 1 year: 1990 ident: 10.1016/j.jss.2006.12.559_bib2 article-title: Role of free radicals and catalytic metal ions in human diseases: An overview publication-title: Methods Enzymol doi: 10.1016/0076-6879(90)86093-B contributor: fullname: Halliwell – volume: 34 start-page: 1236 year: 2003 ident: 10.1016/j.jss.2006.12.559_bib13 article-title: EPR imaging of reducing activity in Nrf2 transcriptional factor deficient mice publication-title: Free Radical Bio Med doi: 10.1016/S0891-5849(03)00073-X contributor: fullname: Hirayama – volume: 3 start-page: 83 year: 1985 ident: 10.1016/j.jss.2006.12.559_bib6 article-title: Factors affecting nitroxide reduction in ascorbate solution and tissue homogenate publication-title: Magn Reson Imaging doi: 10.1016/0730-725X(85)90012-8 contributor: fullname: Couet – volume: 43 start-page: 724 year: 2004 ident: 10.1016/j.jss.2006.12.559_bib17 article-title: Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-α-induced interleukin-8 expression in endothelial cells though its antioxidative properties publication-title: J Cardiovasc Pharmacol doi: 10.1097/00005344-200405000-00016 contributor: fullname: Yamagishi – volume: 18 start-page: 151 year: 2000 ident: 10.1016/j.jss.2006.12.559_bib14 article-title: Ex vivo measurement of tissue distribution of nitroxide radical after intravenous injection and its in vivo imaging using a rapid scan ESR-CT system publication-title: Magn Reson Imaging doi: 10.1016/S0730-725X(99)00122-8 contributor: fullname: Togashi – volume: 51 start-page: 1087 year: 2006 ident: 10.1016/j.jss.2006.12.559_bib22 article-title: Hepatic ischemia-reperfusion injury: Role of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage publication-title: Digestive Dis Sci doi: 10.1007/s10620-006-8014-y contributor: fullname: Nieuwenhuijs – volume: 271 start-page: 15182 year: 1996 ident: 10.1016/j.jss.2006.12.559_bib1 article-title: 1996. Cellular oxygen toxicity publication-title: J Biol Chem doi: 10.1074/jbc.271.25.15182 contributor: fullname: Kazzaz – volume: 64 start-page: 869 year: 1999 ident: 10.1016/j.jss.2006.12.559_bib10 publication-title: Life Sci doi: 10.1016/S0024-3205(99)00011-9 contributor: fullname: Miyazaki – volume: 40 start-page: 1166 year: 2006 ident: 10.1016/j.jss.2006.12.559_bib12 article-title: Synthesis and characterization of practically better DEPMPO-type spin trap,5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide (CYPMPO) publication-title: Free Radical Res doi: 10.1080/10715760600883254 contributor: fullname: Kamibayashi – volume: 434 start-page: 652 year: 2005 ident: 10.1016/j.jss.2006.12.559_bib21 article-title: Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death publication-title: Nature doi: 10.1038/nature03317 contributor: fullname: Nakagawa – start-page: 153 year: 1995 ident: 10.1016/j.jss.2006.12.559_bib3 article-title: Metabolism and distribution of nitroxides in vivo contributor: fullname: Swart – volume: 90 start-page: 143 year: 2002 ident: 10.1016/j.jss.2006.12.559_bib16 article-title: Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-α publication-title: Cir Res doi: 10.1161/hh0202.103615 contributor: fullname: Li – volume: 37 start-page: 3377 year: 1988 ident: 10.1016/j.jss.2006.12.559_bib7 article-title: Inhibition of calmodulin function by CV159, a novel dihydropyridine compound publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(88)90685-5 contributor: fullname: Umekawa – volume: 105 start-page: 1142 year: 1982 ident: 10.1016/j.jss.2006.12.559_bib8 article-title: Interaction of calcium antagonist with cyclic AMP phosphodiesterases and calmodulin publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(82)91089-0 contributor: fullname: Epstein |
SSID | ssj0002973 |
Score | 1.898127 |
Snippet | We investigated the organ-reducing ability of 1,2-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 49 |
SubjectTerms | Alanine Transaminase - blood Animals Biological and medical sciences Calcium - antagonists & inhibitors Calmodulin - antagonists & inhibitors CaM CV159 Dihydropyridines - pharmacology Disease Models, Animal Electron Spin Resonance Spectroscopy ex vivo EPR General aspects hepatic IR injury in vivo EPR Liver - drug effects Liver - metabolism Liver - pathology Male Medical sciences Mitochondria - drug effects Mitochondria - ultrastructure Myosin-Light-Chain Kinase - antagonists & inhibitors Oxidative Stress - drug effects Rats Rats, Sprague-Dawley Reactive Oxygen Species - metabolism Reperfusion Injury - metabolism Reperfusion Injury - pathology Surgery Survival Rate |
Title | The Role of the New Ca2+ Antagonist, CV159, in Hepatic I/R Injury—The Evaluation of Hepatic Organ Reducing Activity Using In Vivo and Ex Vivo EPR |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S002248040601184X https://dx.doi.org/10.1016/j.jss.2006.12.559 https://www.ncbi.nlm.nih.gov/pubmed/18067923 https://search.proquest.com/docview/70303382 |
Volume | 145 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWywUJIRCv8Chz4AQbmtiu6x6rqqsWpBWq2FVvlpM4UqtVUpEu4oT4D_AL-SXM2HFXKx4HbpGVOM7MeGbi-WaGsVdotJWzBU9z_L1KZSFsqgvKRqOeOLpQee08QPZMLc7lu_VofcRmMReGYJW97g863WvrfmTYU3O422woxxfNj0YhVJQ9KdeUwY7mD2X67ddrmAf1ZooVw-nuGNn0GK9tFyp204ngiMqV_tk23dnZDilWh1YXf_dFvU06vcfu9s4kTMN677Mj1zxg35HzsGovHbQ1oHsHqMdgZvkbmDYUgqJSuScwu0AP4wQ2DSwcgapLWA5XsGy2SOOf337QHPNDIXCaKd7mkzdhRRVf0erBtAztJ8BjD3ACuNh8bsE2Fcy_hOv5h9VDdn46_zhbpH3rhbQcZXyfoh_GhZCqQm8CdcK4KPJS6bGts6wqNReW27rmOCrKSo2rsignrnZKy9LjbIR4xI6btnFPGFgpkU8T6biyUnOrkV-24rn39nSeJex1JLrZhQobJkLPtgY5RJ0ylcm5QQ4lbBzZYmLqKCo71_U7rzO56bjJzG_SkTB5ePKGgBm0Hf964eAG8w9L5BST1JNRwl5GaTC4MyncYhvXXnWGdKkQmifscRCS68_TdHzHxdP_W9MzdjugVggJ95wd7z9duRfoGu2LgZf9Abs1Xb5fnP0C0AQJkw |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfGeAAJoSH-Bdh2DzzBQhPbdd3HqurUwphQtU19s5zEkVqhpCId4gnxHeAT8km4i-NO0wYPvEVW4ji-890v9u_uGHuNTls5m_E4xd-rWGbCxjqjaDSqiaMzlZauJciequm5fL_oL3bYOMTCEK2ys_3eprfWumvpdbPZWy-XFOOL7kejEiqKnpSLO-yuJHyMSv3u-xXPg4ozhZThdHs42mxJXqvGp-ymLcE-5Su93Tk9WNsGp6z0tS7-DkZbp3S8xx52aBJGfsCP2I6rHrOfKHqY158d1CUgvgM0ZDC2_C2MKjqDoly5RzC-QIhxBMsKpo5Y1TnMenOYVSuc5N8_flEfk20mcOop3NZGb8KcUr6i24NR7utPQEs-wA7gYvm1BlsVMPnmryef5k_Y-fHkbDyNu9oLcd5P-CZGIMaFkKpAOIFGYZBlaa70wJZJUuSaC8ttWXJsFXmhBkWe5UNXOqVl3hJthHjKdqu6cs8ZWClRUEPpuLJSc6tRYLbgaQv3dJpE7E2YdLP2KTZM4J6tDEqISmUqk3KDEorYIIjFhNhRtHau6ZZeY1LTcJOYG-oRMbl98pqGGXQe_3rhwTXhb4fI6VBSD_sROwzaYHBp0nmLrVx92RgypkJoHrFnXkmuPk_T_h0XL_5vTIfs3vTs44k5mZ1-eMnuewoL0eJesd3Nl0u3jzhpkx206-AP6gILLA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+the+New+Ca2%2B+Antagonist%2C+CV159%2C+in+Hepatic+I%2FR+Injury+%3A+The+Evaluation+of+Hepatic+Organ+Reducing+Activity+Using+In+Vivo+and+Ex+Vivo+EPR&rft.jtitle=The+Journal+of+surgical+research&rft.au=WATANABE%2C+Taiji&rft.au=OOWADA%2C+Shigeru&rft.au=NAKANO%2C+Hiroshi&rft.au=KUBOTA%2C+Sunao&rft.date=2008-03-01&rft.pub=Elsevier&rft.issn=0022-4804&rft.eissn=1095-8673&rft.volume=145&rft.issue=1&rft.spage=49&rft.epage=56&rft_id=info:doi/10.1016%2Fj.jss.2006.12.559&rft.externalDBID=n%2Fa&rft.externalDocID=20122895 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00224804%2FS0022480408X05219%2Fcov150h.gif |